CSIR and Aurobindo Pharma to collaborate for COVID-19 vaccine development EP News Bureau Sep 16, 2020 DBT is also supporting Aurobindo Pharma’s COVID-19 vaccine development through its wholly-owned US subsidiary Auro Vaccines, under…
Aurobindo Pharma expects Phase I and II trials of COVID-19 vaccine by end of 2020 Press Trust of India Aug 14, 2020 The company's viral vaccine manufacturing capacity in India would be undertaken in two phases, the first phase would be ready by…
Aurobindo Pharma joins COVID-19 vaccine hunt Press Trust of India Aug 8, 2020 The company’s vaccine candidate has been shortlisted for BIRAC funding, will launch final product by the end of 2022
